Watch the Fireside Chat video and read the summary below. We are in something of a race between COVID-19 vaccines and emerging virus variants, and many questions still...
Age-related macular degeneration (AMD) is a leading cause of vision loss, and those over the age of 75 have a nearly 30% risk of being affected....
A rare disease diagnosis for a loved one can be devastating. The majority of rare diseases are pediatric, meaning they affect children from birth or early...
Rare diseases are anything but rare – with more than 7,000 uniquely identified, they cumulatively affect more than 300 million patients worldwide. The majority of these...
There is finally a light at the end of the COVID-19 pandemic tunnel, thanks to a historic vaccine development effort. What will it take to bring...
After a long 10 months, COVID-19 vaccines are finally here. The next obstacle? Determining how to distribute them efficiently, ethically, and economically. Last week, experts in...
Watch the Fireside Chat video and read the summary below. After a historic research effort, COVID-19 vaccines are already here. Several of these vaccines, including the...
Racial and ethnic minorities are disproportionately affected by virtually every major disease of our time, and this gap has only been exacerbated by COVID-19. This year,...
Cover photo: Dr. Valentina Fossati (NYSCF) and Jason Stein (Aspen Neuroscience) prepare cells for launch. Photo credit: Space Tango Why send cells affected by multiple sclerosis...
“My oldest son, Andrew, is a cancer survivor,” said Tony Coles, MD, PhD, CEO of Cerevel Therapeutics. “He was afflicted with non-Hodgkins lymphoma when he...
Hosted by CNN’s Chief Medical Correspondent Sanjay Gupta, MD, this year’s New York Stem Cell Foundation Research Institute Gala & Science Fair went virtual for the...
It has been six months since the COVID-19 pandemic hit the United States at full force, leaving millions sick, out of work, and desperate for new...
Today, more than 6 million Americans suffer from neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and multiple sclerosis, and as our society ages, that number is only...
Ovarian cancer is a difficult disease to tackle, as is evident from the statistics that surround it: Five years after diagnosis, ovarian cancer survival rates are...
Featured image credit: National Institute of Allergy and Infectious Diseases What makes the COVID-19 virus so hard to contain? Why do some people have severe reactions? What...
The COVID-19 pandemic has upended society, leaving millions sick and out of work. Fortunately, scientists have started a global race to understand the virus, halt its...
NYSCF – Robertson Neuroscience Investigator Alumna and Salk Institute Professor Kay Tye, PhD, recently delivered a TED Talk on her pioneering work to illuminate how circuits...
“How many people were promised a cure [for type 1 diabetes] within five or ten years?” JDRF CEO Aaron Kowalski asks the audience. Half the hands...
Alzheimer’s remains one of the most devastating diseases in the world, and though there are more than 44 million people with it worldwide, there are still...
Perhaps in the past few years, you’ve started to hear more about CRISPR gene editing— the revolutionary technique that allows us to precisely manipulate the DNA...
“I got involved in type one diabetes advocacy over 25 years ago when my son was diagnosed,” said NYSCF CEO Susan L. Solomon, JD. “At that...
Women’s reproductive cancers—such as ovarian cancer, endometrial cancer, uterine cancer, and cervical cancer—are especially difficult to treat. Mortality rates are high (32,000 women die from these...
The Context: In multiple sclerosis, the immune system attacks myelin (the fatty substance that surrounds neurons and helps them send signals). Currently, there are no...
44 million people worldwide are affected by Alzheimer’s. 1 in 3 seniors will die with it or a related dementia. The cost of treating Alzheimer’s is...
What They Did: A team of NYSCF scientists led by NYSCF – Ralph Lauren Senior Principal Investigator Dr. Giuseppe Maria de Peppo tested whether mesenchymal progenitor...
